The first pill designed to treat symptomatic Covid has been approved by the UK medicines regulator.
The tablet – molnupiravir – will be given twice a day to vulnerable patients recently diagnosed with the disease.
In clinical trials the pill, originally developed to treat flu, cut the risk of hospitalisation or death by about half.